$7.1 Million in revenue for the first nine months of fiscal 2026 from commercial sales of LYMPHIR ® $17 million in cash and cash equivalents as of June 30, 2026 Expanded LYMPHIR commercial and medical affairs organizations deployed nationwide CRANFORD, N.J., Aug. 14, 2026 /PRNewswire/ --...
Hence then, the article about citius pharmaceuticals inc reports fiscal third quarter 2026 financial results and provides business update was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update )
Also on site :
- Clarks’ ‘Comfortable’ Loafers Have Shoppers Walking ‘All Day With No Fatigue,’ and They’re on Sale for $60
- We Asked 3 Disney Travel Experts for the Best Multigenerational Family Vacation Upgrade—They All Said the Same Thing
- Ted Lasso's Jason Sudeikis And Brett Goldstein Team With Sesame Street's Elmo And Oscar For Daily Affirmations — Watch Or Scram!